Within the injectables platform, the Zagreb hub focuses on four dedicated areas:
Formulation development
Analytical development
Medical science for injectables
New product transfer
Strengthening delivery. Expanding capabilities.
We are strengthening delivery in projects of increasing complexity, while expanding capabilities in new and emerging areas
Complex generics, including peptides and polypeptides
Differentiated ready-to-administer injectable formulations
Long-acting injectables
Oligonucleotides
Strong internal expertise
Our team is built on scientific expertise, with 80% of employees holding a Master’s degree and 40% holding a PhD. This strong academic foundation underpins a high level of innovation and technical excellence.
We demonstrate robust intellectual property activity, particularly in differentiated ready-to-administer injectable formulations, with a growing portfolio that includes granted patents, active applications, and new filings in development.
Key information
Hikma d.o.o.
Slavonska Avenija 24/6, 10000 Zagreb, Croatia
Phone:
+385 1 6278569